Morphine Sulfate Injection Recalled for Lack of Sterility Assurance
SterRx is recalling 40 bags of Morphine Sulfate in 5% Dextrose Injection (1 mg per mL) distributed nationwide due to lack of assurance of sterility. The product is subject to contamination risk.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterile injectable drug product. Lack of sterility assurance in injectable medications presents serious risk of infection and harm; the product is administered intravenously where contamination poses direct patient safety risk.
Plain-English summary
SterRx, LLC is recalling Morphine Sulfate in 5% Dextrose Injection, 100 mg per 100 mL (1 mg per mL), NDC 70324-452-01, lot code S21293/BYJ, due to lack of assurance of sterility.
The recalled product was distributed nationwide in the United States. A total of 40 bags are affected by this recall.
Patients who have received this product should contact their healthcare provider immediately. Healthcare professionals and institutions that have received this product should cease use and contact SterRx for further instructions. No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- Morphine Sulfate in 5% Dextrose Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-452-01.
- Manufacturer
- SterRx, LLC
- Affected units
- 40
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- S21293/BYJ
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by SterRx, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · SterRx, LLC
See all →- HighNorepinephrine injectable recalled due to sterility assurance concerns
FDA (Drugs) · 2023-07-26
- HighNorepinephrine injectable recalled due to lack of sterility assurance
FDA (Drugs) · 2023-07-26
- HighNorepinephrine Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-07-26
- HighNorepinephrine injectable medication recalled nationwide for sterility assurance
FDA (Drugs) · 2023-07-26
- HighSodium Bicarbonate Injectable Solution Recalled for Sterility Assurance Issues
FDA (Drugs) · 2023-07-26
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22